Conning Portfolio holdings
Conning manages money mainly for insurance companies and pension plans, mostly in bonds and stocks. William S. Conning founded the firm in 1912 to give investment advice to high-net-worth individuals, and it began managing investments for insurers in 1983. Conning has grown by buying majority stakes in specialist managers, including Octagon Credit Investors, which focuses on loans and high yield bonds, in 2016, and the emerging markets debt manager Global Evolution, in which it became majority owner in 2020. It is part of Generali Investments, and its controlling shareholder is Generali Investments Holding, based in Italy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$32.4M |
| 2 |
Aflac
AFL
|
+$32M |
| 3 |
Starbucks
SBUX
|
+$30.6M |
| 4 |
HP
HPQ
|
+$9.5M |
| 5 |
Intel
INTC
|
+$5.79M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
3M
MMM
|
+$32.9M |
| 2 |
Eastman Chemical
EMN
|
+$30M |
| 3 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$17.4M |
| 4 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$13.8M |
| 5 |
Invesco Senior Loan ETF
BKLN
|
+$13.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 30.58% |
| 2 | Healthcare | 13.51% |
| 3 | Technology | 11.93% |
| 4 | Financials | 11.88% |
| 5 | Consumer Staples | 10.74% |
Similar funds
Conning's Q3 2022 Portfolio in Review
As of Q3 2022, Conning held 393 positions worth $2.82B, down 16% from $3.34B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Conning withdrew a net $483M in Q3 2022, closing 34 positions and reducing 244 holdings. Its most notable exit was Eastman Chemical, an estimated $30M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 31% of assets, up from 29% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Conning opened a new position in Albemarle worth $205K.
- Conning's largest Q3 2022 buy was Albemarle: 777 shares worth $205K.
- Conning added most to CVS Health in Q3 2022, an estimated $32.4M increase.
- Conning's biggest Q3 2022 reduction was 3M, cutting an estimated $32.9M.
- Conning fully exited Eastman Chemical in Q3 2022, selling an estimated $30M.
- Conning's ten largest holdings make up 15% of its $2.82B portfolio in Q3 2022.
- Conning opened 2 new positions and closed 34 in Q3 2022.
- Conning's portfolio value fell 16% quarter-over-quarter to $2.82B.
Based on Conning's 13F filing for Q3 2022, filed 31 Oct 2022.